Treatment of Autoimmune Thrombocytopenia (AITP)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 21, 1997

Study Completion Date

June 11, 2009

Conditions

Autoimmune DiseaseAutoimmune Hemolytic AnemiaThrombocytopenia

Interventions

DEVICE

Isolex 300i

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001630 - Treatment of Autoimmune Thrombocytopenia (AITP) | Biotech Hunter | Biotech Hunter